1. Home
  2. OPTX vs ITRM Comparison

OPTX vs ITRM Comparison

Compare OPTX & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTX
  • ITRM
  • Stock Information
  • Founded
  • OPTX 1981
  • ITRM 2015
  • Country
  • OPTX United States
  • ITRM Ireland
  • Employees
  • OPTX N/A
  • ITRM N/A
  • Industry
  • OPTX Blank Checks
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • OPTX Finance
  • ITRM Health Care
  • Exchange
  • OPTX Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • OPTX 51.9M
  • ITRM 49.5M
  • IPO Year
  • OPTX N/A
  • ITRM 2018
  • Fundamental
  • Price
  • OPTX $1.79
  • ITRM $1.52
  • Analyst Decision
  • OPTX
  • ITRM Strong Buy
  • Analyst Count
  • OPTX 0
  • ITRM 1
  • Target Price
  • OPTX N/A
  • ITRM $5.00
  • AVG Volume (30 Days)
  • OPTX 2.7M
  • ITRM 620.0K
  • Earning Date
  • OPTX 11-14-2024
  • ITRM 11-14-2024
  • Dividend Yield
  • OPTX N/A
  • ITRM N/A
  • EPS Growth
  • OPTX N/A
  • ITRM N/A
  • EPS
  • OPTX 0.00
  • ITRM N/A
  • Revenue
  • OPTX $29,392,186.00
  • ITRM N/A
  • Revenue This Year
  • OPTX N/A
  • ITRM N/A
  • Revenue Next Year
  • OPTX N/A
  • ITRM N/A
  • P/E Ratio
  • OPTX $1,069.23
  • ITRM N/A
  • Revenue Growth
  • OPTX 4.36
  • ITRM N/A
  • 52 Week Low
  • OPTX $0.85
  • ITRM $0.81
  • 52 Week High
  • OPTX $8.39
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • OPTX 43.82
  • ITRM 38.68
  • Support Level
  • OPTX $2.18
  • ITRM $1.47
  • Resistance Level
  • OPTX $2.43
  • ITRM $2.10
  • Average True Range (ATR)
  • OPTX 0.44
  • ITRM 0.13
  • MACD
  • OPTX -0.17
  • ITRM -0.03
  • Stochastic Oscillator
  • OPTX 8.95
  • ITRM 7.94

About OPTX Syntec Optics Holdings Inc.

Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: